510(k) K990023
K990023 is an FDA 510(k) premarket notification submitted by Digene Corp. for the device "HYBRID CAPTURE II CT-ID TEST". The FDA issued a decision of Substantially Equivalent on October 25, 1999. The device falls under product code LSK (Dna-Reagents, Chlamydia), a Class I device regulated under 21 CFR 866.3120. Digene Corp. has at least 8 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- October 25, 1999
- Date Received
- January 5, 1999
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Dna-Reagents, Chlamydia
- Device Class
- Class I
- Regulation Number
- 866.3120
- Review Panel
- MI
- Submission Type